LSU Health Shreveport researchers recently presented preliminary findings at the American Heart Association’s Basic Cardiovascular Sciences 2019 Scientific Sessions that use of the illegal stimulant methamphetamine causes build-up of tough protein fibers in heart muscle, which may help explain the development of enlarged hearts and heart failure in users.
The primary mission of LSU Health Shreveport (LSUHS) is to teach, heal, and discover, in order to advance the well-being of the region and beyond.
LSU Health Shreveport is home to the only medical school in north Louisiana and one of only three in the state. A medical school is a tertiary educational institution teaching medicine resulting in a professional degree for physicians.
Offering degrees in Cardiopulmonary Science, Medical Laboratory Science, Physician Assistant, Communication Disorders, Occupational Therapy, Physical Therapy, and Public Health
Offering Graduate Degrees in Biochemistry & Molecular Biology, Cellular Biology & Anatomy, Microbiology & Immunology, Molecular & Cellular Physiology, and Pharmacology, Toxicology, & Neuroscience.
GME stands for "graduate medical education" more commonly referred to as residency. This is the training physicians must complete to practice following medical school.
The goal of medical research at LSU Health Shreveport is to improve our health and extends from basic science discovery to the development of treatment protocols and new diagnostics.
LSU Health Shreveport is honored and imminently qualified to offer a broad range of clinical trials. As an academic medical center, we recognize the value of clinical research both in helping patients today and in finding the cures of tomorrow.
A paper authored by many researchers at LSU Health Shreveport on the prevention and treatment of stroke was recently published in Circulation, a journal of the American Heart Association.
Landmark trial looking for potential candidates
LSU Health Shreveport professor Dr. Yuping Wang trained lab staff and her patented research techniques will be utilized in their work.
The Louisiana Board of Regents unanimously approved the continuation of the Center for Cardiovascular Diseases and Sciences (CCDS) as a Center of Excellence of research and innovation.
Since July 1, 2018, 17 new research grants have been awarded to LSU Health Shreveport researchers, totaling more than $14 million dollars in funding.
Four trainees in the Center for Cardiovascular Diseases and Sciences at LSU Health Shreveport recently received American Heart Association Fellowships to fund their Pre-doctoral and Post-doctoral Training.